Howard Burris

10PUBLICATIONS

97CO-AUTHORS

Cancer cell biologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 01, 2026

Clinical Research in Community Oncology: Advancing Cancer Care Through Localized Clinical Trials.

|Oct 07, 2025

The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Alison M Schram, Abdul Rafeh Naqash, Eric B Haura

|Jun 13, 2025

ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.

Funda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney

|Mar 19, 2025

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

Reinhard Dummer, Shahneen Sandhu, Wilson H Miller

|Mar 18, 2025

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.

William D Tap, Gregory M Cote, Howard Burris

|Aug 08, 2024

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Justin F Gainor, Manish R Patel, Jeffrey S Weber

Pageof 2

Frequent Collaborators

Aditya Bardia

Debu Tripathy

Seock-Ah Im

Justin F Gainor

Manish R Patel

Jeffrey S Weber

Martin Gutierrez

Julie E Bauman

Jeffrey M Clarke

Ricklie Julian

Frequent Collaborators

Aditya Bardia

Debu Tripathy

Seock-Ah Im

Justin F Gainor